Models and Biomarkers for Local Response Prediction in Early-Stage and Oligometastatic Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy Using Machine Learning

Background A minority of patients receiving stereotactic body radiation therapy (SBRT) for non-small cell lung cancer (NSCLC) are not good responders. Radiomic features can be used to generate predictive algorithms and biomarkers that can determine treatment outcomes and stratify patients to their therapeutic options. This study investigated and attempted to validate the radiomic and clinical features obtained from early-stage and oligometastatic NSCLC patients who underwent SBRT, to predict local response. Methodology A single-institution, Institutional Review Board (IRB)-approved retrospective review was conducted on adult patients with early-stage and oligometastatic SBRT-treated NSCLC at the Jewish General Hospital. The study included 98 patients (82 with early-stage NSCLC and 16 with oligometastatic disease), with a median age of 76 years and a male-to-female ratio of 46:52. A total of 116 lesions were treated with SBRT between 2009 and 2022. Radiomics features (n = 107) were extracted from CT planning scans using PyRadiomics, and clinical data were collected for all 98 patients. Local response was assessed according to Response Evaluation Criteria In Solid Tumors (RECIST 1.1) criteria. Classification models, including support vector machines, random forests, adaptive boosting, and multi-layer perceptrons (MLPs), were used. Models were trained using a fivefold cross-validation scheme. Their performances were measured with receiver operating characteristic plots on the validation folds. Using the importance of the permutation feature, predictive biomarkers were identified. Results The most predictive model, incorporating all patients and using an MLP classifier with Adaptive Synthetic (ADASYN) sampling, a combined-input approach, and a radiomic filter, achieved an area under the curve (AUC) of 0.94 ± 0.05. When oligometastatic patients were omitted, the best model (AUC 0.95 ± 0.06) was also predictive, using a support vector classification (SVC) radial basis function (RBF) classifier, ADASYN sampling, and a clinical-based input. Treatment site and performance status, along with radiomic features such as first-order root-mean-squared-intensity, first-order skewness, and gray-level nonuniformity, were found to be predictive biomarkers. Conclusions The predictive models generated and the biomarkers identified could be used in clinical decision support systems for SBRT-treated NSCLC patients. Additionally, treatment site, performance status, and radiomic features were the most predictive variables.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.